Non-Small Cell Lung Cancer (NSCLC) Harboring EGFR Mutations (EGFR-m) and Breast Cancer (BC): A Retrospective Analysis

被引：0
|
作者：
Moran, Teresa [1 ]
Quiroga, Vanesa [1 ]
Carcereny, Enric [1 ]
Cirauqui, Beatriz [1 ]
Margeli, Mireia [1 ]
Vila, Laia [1 ]
De Los, Maria [1 ]
机构：
[1] Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Med Oncol, Badalona, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
EGFR mutations; Breast Cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MINI13.13
引用
收藏
页码：S310 / S311
页数：2
相关论文
共 50 条
  • [21] Adjuvant Treatments for Surgically Resected Non-Small Cell Lung Cancer Harboring EGFR Mutations A Review
    Passaro, Antonio
    Mok, Tony S. K.
    Attili, Ilaria
    Wu, Yi-Long
    Tsuboi, Masahiro
    de Marinis, Filippo
    Peters, Solange
    JAMA ONCOLOGY, 2023, 9 (08) : 1124 - 1131
  • [22] Uncommon EGFR mutations in advanced non-small cell lung cancer
    O'Kane, Grainne M.
    Bradbury, Penelope A.
    Feld, Ronald
    Leighl, Natasha B.
    Liu, Geoffrey
    Pisters, Katherine -M.
    Kamel-Reid, Suzanne
    Tsao, Ming S.
    Shepherd, Frances A.
    LUNG CANCER, 2017, 109 : 137 - 144
  • [23] Treatment of Non-Small Cell Lung Cancer with Atypical EGFR Mutations
    Leah Wells
    Angel Qin
    Current Treatment Options in Oncology, 2023, 24 : 1802 - 1814
  • [24] EGFR mutations in non-small cell lung cancer - Clinical implications
    Charpidou, Andriani
    Blatza, Despoina
    Anagnostou, Elsa
    Syrigos, Konstantinos N.
    IN VIVO, 2008, 22 (04): : 529 - 536
  • [25] Treatment of Non-Small Cell Lung Cancer with Atypical EGFR Mutations
    Wells, Leah
    Qin, Angel
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2023, 24 (12) : 1978 - 1993
  • [26] Impact of EGFR mutations on treatment of non-small cell lung cancer
    Bruce E. Johnson
    David Jackman
    Pasi A. Jänne
    Cancer Chemotherapy and Pharmacology, 2006, 58 : 5 - 9
  • [27] Impact of EGFR mutations on treatment of non-small cell lung cancer
    Johnson, Bruce E.
    Jackman, David
    Janne, Pasi A.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (Suppl 1) : S5 - S9
  • [28] DETECTING EGFR MUTATIONS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Hammoudeh, Z. A.
    Antonova, O.
    Staneva, R.
    Nikolova, D.
    Kyuchukov, Y.
    Penev, A.
    Mintchev, T.
    Koleva, V
    Hadjidekova, S.
    Toncheva, D.
    BALKAN JOURNAL OF MEDICAL GENETICS, 2018, 21 (01) : 13 - 17
  • [29] Clinical Features of Patients with Non-Small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) Mutations in Brunei
    Lu, S. K.
    Leong, C. H.
    Diah, S. Binti Hj Mohd
    Patnaik, R.
    Sukumaran, B.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2207 - S2207
  • [30] EGFR tyrosine kinase inhibitors in non-small cell lung cancer (NSCLC) with EGFR activating mutations - real world data
    Dulloo, Sean
    Almusarhed, Manar
    Chen, Ryan
    Akala, Oyeyemi
    Varadhan, Balaji
    Chauhan, Meera
    Ahmed, Samreen
    LUNG CANCER, 2021, 156 : S40 - S40
12345